Sign Up to like & get
recommendations!
0
Published in 2019 at "Hematological Oncology"
DOI: 10.1002/hon.240_2631
Abstract: del17p – 5.6% (9/159); 1p32/1q21 amp/del – 12% (19/159); hypodiploidy – 3.1% (5/159); hyperdiploidy – 1.25% (2/159); del5q – 0,6% (1/159); other – not found. Combination two aberrations was discovered in 11.9% (19/159) patients, complex…
read more here.
Keywords:
risk;
risk msmart;
median pfs;
complex abnormalities ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2019 at "International Journal of Hematology"
DOI: 10.1007/s12185-019-02703-0
Abstract: The standard treatment for adult acute lymphoblastic leukemia (ALL) is undefined. Patients with newly diagnosed standard-risk ALL at a single institution were retrospectively analyzed. From 2010 to 2017, 46 patients were treated using the modified…
read more here.
Keywords:
risk;
newly diagnosed;
lymphoblastic leukemia;
standard risk ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
2
Published in 2020 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2019.12.486
Abstract: Introduction MM is a clonal disorder of malignant plasma cells. Standard of care for newly diagnosed MM is induction with triplet regimen chemotherapy followed by ASCT. Patients are stratified based on cytogenetic analysis as being…
read more here.
Keywords:
risk;
newly diagnosed;
high risk;
standard risk ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2017 at "British Journal of Haematology"
DOI: 10.1111/bjh.14854
Abstract: We retrospectively investigated outcomes of haploidentical donor (HID) transplant for adults with standard‐risk acute lymphoblastic leukaemia (ALL) in first complete remission (CR1) compared with human leucocyte antigen (HLA)‐matched sibling donor (MSD) and HLA‐matched unrelated donor…
read more here.
Keywords:
risk acute;
year;
standard risk;
transplantation ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2019 at "Clinical Cancer Research"
DOI: 10.1158/1078-0432.ccr-19-0706
Abstract: Purpose: Patients with multiple myeloma with t(11;14) have been considered to have standard-risk disease. However, several recent reports have shown contradictory results. We identified 95 patients with multiple myeloma with t(11;14) on FISH studies, who…
read more here.
Keywords:
risk control;
patients multiple;
multiple myeloma;
standard risk ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-129402
Abstract: The survival rate of childhood acute lymphoblastic leukemia (ALL) has reached >80-90% in developed countries, which is a triumph of modern medicine. This success is due to implementation of contemporary treatment protocols, optimal application of…
read more here.
Keywords:
risk group;
risk;
high risk;
treatment ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Blood"
DOI: 10.1182/blood-2020-141895
Abstract: Introduction Multiple myeloma (MM) is a malignancy involving terminally differentiated plasma cells. Its incidence in India is about 0.7/1,00,000 population amounting to about 6,800 new cases a year A number of genomic aberrations are associated…
read more here.
Keywords:
risk group;
risk;
fish analysis;
high risk ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.22207
Abstract: Patients with standard-risk adult acute lymphoblastic leukemia (ALL) treated with chemotherapy do not have satisfactory outcomes. To more precisely classify ALL patients and optimize treatment, we re-evaluated the risk stratification system by examining CD20 expression…
read more here.
Keywords:
risk;
cd20 positive;
standard risk;
cd20 negative ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2020 at "Haematologica"
DOI: 10.3324/haematol.2019.243428
Abstract: Despite remarkable advances in the treatment of multiple myeloma (MM) in the last decades, the prognosis of patients harboring highrisk cytogenetic abnormalities remains dismal as compared to that of standard-risk patients. Proteasome inhibitors have been…
read more here.
Keywords:
risk;
carfilzomib cyclophosphamide;
high risk;
analysis ... See more keywords